Pulse Biosciences (PLSE) Competitors $17.28 -0.39 (-2.18%) As of 02:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. TMDX, NVST, LIVN, SLNO, WRBY, INSP, LQDA, LMAT, PRCT, and AORTShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. Its Competitors TransMedics Group Envista LivaNova Soleno Therapeutics Warby Parker Inspire Medical Systems Liquidia Technologies LeMaitre Vascular PROCEPT BioRobotics Artivion Pulse Biosciences (NASDAQ:PLSE) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment. Do analysts prefer PLSE or TMDX? Pulse Biosciences presently has a consensus target price of $22.00, indicating a potential upside of 27.28%. TransMedics Group has a consensus target price of $125.40, indicating a potential upside of 9.91%. Given Pulse Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Pulse Biosciences is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TransMedics Group 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has higher valuation and earnings, PLSE or TMDX? TransMedics Group has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,661.83-$53.58M-$1.05-16.46TransMedics Group$531.29M7.32$35.46M$1.9359.11 Do institutionals and insiders believe in PLSE or TMDX? 77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 74.6% of Pulse Biosciences shares are held by insiders. Comparatively, 7.0% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, PLSE or TMDX? Pulse Biosciences has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.18, indicating that its share price is 118% more volatile than the S&P 500. Is PLSE or TMDX more profitable? TransMedics Group has a net margin of 13.49% compared to Pulse Biosciences' net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -63.19% -54.98% TransMedics Group 13.49%28.02%8.64% Does the media favor PLSE or TMDX? In the previous week, Pulse Biosciences had 2 more articles in the media than TransMedics Group. MarketBeat recorded 9 mentions for Pulse Biosciences and 7 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.89 beat Pulse Biosciences' score of 0.47 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TransMedics Group 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTransMedics Group beats Pulse Biosciences on 11 of the 16 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16B$6.51B$5.65B$10.26BDividend YieldN/A1.20%5.68%4.61%P/E Ratio-16.3925.0275.7026.05Price / Sales1,661.83197.55514.05168.79Price / CashN/A21.7937.5661.52Price / Book9.245.0112.876.29Net Income-$53.58M$178.07M$3.29B$270.94M7 Day Performance-6.67%-1.59%-0.33%-0.30%1 Month Performance4.82%5.89%3.77%6.20%1 Year Performance2.10%22.62%68.18%28.32% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences4.1821 of 5 stars$17.29-2.2%$22.00+27.3%+3.1%$1.16B$700K-16.39140Positive NewsInsider TradeGap UpTMDXTransMedics Group2.7495 of 5 stars$114.29-0.2%$122.11+6.8%-24.7%$3.91B$531.29M59.22210Gap DownNVSTEnvista3.9401 of 5 stars$21.12+0.5%$20.92-0.9%+9.3%$3.49B$2.55B65.9912,300LIVNLivaNova3.2243 of 5 stars$55.43-1.4%$59.71+7.7%+3.4%$3.07B$1.31B-14.252,900Positive NewsSLNOSoleno Therapeutics4.437 of 5 stars$51.17-4.6%$115.09+124.9%+37.6%$2.85BN/A-12.3630Trending NewsWRBYWarby Parker1.4618 of 5 stars$26.37-1.4%$24.06-8.8%+85.2%$2.81B$771.32M-376.723,780INSPInspire Medical Systems4.8309 of 5 stars$80.90+1.1%$164.50+103.3%-62.5%$2.37B$861.31M46.761,246Analyst DowngradeLQDALiquidia Technologies3.8883 of 5 stars$26.77+3.0%$32.11+20.0%+116.8%$2.24B$19.32M-15.7550Positive NewsGap UpLMATLeMaitre Vascular3.6385 of 5 stars$92.37+0.1%$97.60+5.7%-3.7%$2.09B$219.86M44.84490Positive NewsAnalyst ForecastPRCTPROCEPT BioRobotics2.5856 of 5 stars$38.00+2.3%$70.00+84.2%-52.5%$2.07B$224.50M-24.52430Positive NewsAORTArtivion2.665 of 5 stars$39.74-2.4%$40.63+2.2%+60.4%$1.92B$388.54M-94.621,600 Related Companies and Tools Related Companies TMDX Competitors NVST Competitors LIVN Competitors SLNO Competitors WRBY Competitors INSP Competitors LQDA Competitors LMAT Competitors PRCT Competitors AORT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLSE Stock Alerts